Sales Agreements in the Pharmaceuticals Industry

232 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
TETRALOGIC PHARMACEUTICALS CORPORATION AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT
Sales Agreements
TETRALOGIC PHARMACEUTICALS CORP
Pharmaceuticals
NY
2015
Controlled Equity OfferingSM Sales Agreement, dated November 6, 2024, between SCYNEXIS, Inc. and Cantor Fitzgerald & Co
Sales Agreements
SCYNEXIS INC
2024
Capital on Demand Sales Agreement, dated as of August 21, 2024, by and between Lexaria Bioscience Corp. and JonesTrading Institutional Services LLC
Sales Agreements
Lexaria Bioscience Corp.
2024
Sales Agreement, dated July 26, 2024, by and between CNS Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners
Sales Agreements
CNS Pharmaceuticals, Inc.
2024
Sales Agreement, dated May 10, 2024, by and between Edgewise Therapeutics, Inc. and Leerink Partners LLC
Sales Agreements
Edgewise Therapeutics, Inc.
2024
Sales Agreement dated April 26, 2024 by and between Lipocine Inc., and A.G.P./Alliance Global Partners
Sales Agreements
Lipocine Inc.
2024
Open Market Sales AgreementSM, dated as of March 22, 2024, by and between the Company and Jefferies LLC
Sales Agreements
resTORbio, Inc.
2024
Sales Agreement, dated March 20, 2024, by and between Cumberland Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC
Sales Agreements
CUMBERLAND PHARMACEUTICALS INC
2024
Sales Agreement, dated as of
Sales Agreements
Menlo Therapeutics Inc.
2024
Amendment No. 10 on October 31, 2023 to the Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014
Sales Agreements
NGM BIOPHARMACEUTICALS INC
2023
Controlled Equity OfferingSM Sales Agreement, dated September 1, 2023, between Lyra Therapeutics, Inc. and Cantor Fitzgerald & Co
Sales Agreements
Lyra Therapeutics, Inc.
2023
Amendment No. 1 to the Sales Agreement, dated as of August
Sales Agreements
Cerecor Inc.
2023
Sales Agreement
Sales Agreements
Adamis Pharmaceuticals Corp
2023
Controlled Equity Offering Sales Agreement dated July 21, 2023 by and between Hepion Pharmaceuticals, Inc., and Cantor Fitzgerald & Co
Sales Agreements
ContraVir Pharmaceuticals, Inc.
2023
Sales Agreement, dated June 16, 2023, by and between Edgewise Therapeutics, Inc. and BofA Securities, Inc
Sales Agreements
Edgewise Therapeutics, Inc.
2023
Sales Agreement, dated as of May 24, 2023, by and between Eloxx Pharmaceuticals, Inc. and Oppenheimer & Co. Inc
Sales Agreements
Eloxx Pharmaceuticals, Inc.
2023
Sales Agreement, dated May 15, 2023, by and between Terns Pharmaceuticals, Inc. and Cowen and Company, LLC
Sales Agreements
Terns Pharmaceuticals, Inc.
2023
Controlled Equity OfferingSM Sales Agreement, dated as of May 12, 2023, by and between the Company and Cantor Fitzgerald & Co
Sales Agreements
Clearside Biomedical, Inc.
2023
Sales Agreement, dated as of May
Sales Agreements
Cerecor Inc.
2023
Capital On Demand Sales Agreement, dated as of May 1, 2023, between Cassava Sciences, Inc. and JonesTrading Institutional Services LLC
Sales Agreements
CASSAVA SCIENCES INC
2023
Sales Agreement, dated February 23, 2023, by and among Aclaris Therapeutics, Inc., SVB Securities LLC and Cantor Fitzgerald & Co
Sales Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2023
Controlled Equity Offering Sales AgreementSM, dated January 6, 2023, among the Company, Cantor Fitzgerald & Co. and BTIG, LLC
Sales Agreements
Athira Pharma, Inc.
Pharmaceuticals
NY
2023
Controlled Equity OfferingSM Sales Agreement, dated as of December 23, 2022, by and among Cognition Therapeutics, Inc., Cantor Fitzgerald & Co. and B. Riley Securities, Inc
Sales Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
NY
2022
At-The-Market Sales Agreement by and between the Registrant and Virtu Americas LLC, dated November 3, 2022
Sales Agreements
Satsuma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Controlled EquitySM Sales Agreement, dated August 24, 2022, by and among Rani Therapeutics Holdings, Inc., and Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC
Sales Agreements
Rani Therapeutics Holdings, Inc.
Pharmaceuticals
NY
2022
Third Amendment to Sales Promotion and Distribution Agreement, dated as of July 15, 2020, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International...
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2022
Amendment No. 1 to the Sales Agreement, dated May 13, 2022, by and between the Registrant and SVB Securities LLC
Sales Agreements
Trevi Therapeutics, Inc.
Pharmaceuticals
NY
2022
Master Manufacturing and Supply Agreement, dated August 16, 2018, by and between DPT Laboratories, Ltd. and EPI Health, LLC (as successor-in-interest to Allergan Sales, LLC)
Sales Agreements
Novan, Inc.
Pharmaceuticals
NJ
2022
Sales Agreement - 6220 E. Dyer Santa Ana
Sales Agreements
Terra Tech Corp.
Pharmaceuticals
CA
2022
Sales Agreement dated as of March 17, 2022, by and between the Company and Cowen and Company, LLC
Sales Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Sales Agreement, dated as of December 17, 2021, by and between the Company and Roth Capital Partners, LLC
Sales Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2022
Sales Agreement, dated as of March 3, 2022, by and between Tilray Brands, Inc. and Jefferies LLC and Canaccord Genuity LLC
Sales Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Sales Agreement dated March 1, 2022, by and between Axsome Therapeutics, Inc. and SVB Securities LLC
Sales Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2022
Controlled Equity OfferingSM Sales Agreement dated January 10, 2022 by and among Agile Therapeutics, Inc. and Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC
Sales Agreements
AGILE THERAPEUTICS INC
Pharmaceuticals
NY
2022
Sales Agreement dated December 28, 2021 between the Registrant and ThinkEquity LLC
Sales Agreements
ProPhase Labs, Inc.
Pharmaceuticals
NY
2021
Amendment No. 1 to the At Market Issuance Sales Agreement, dated December 27, 2021, by and between Cumberland Pharmaceuticals Inc. and B. Riley Securities, Inc. (formerly B. Riley...
Sales Agreements
CUMBERLAND PHARMACEUTICALS INC
Pharmaceuticals
NY
2021
Sales Agreement, dated as of September 30, 2021, by and between Eloxx Pharmaceuticals, Inc. and SVB Leerink, LLC
Sales Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Sales Agreement, dated as of September 8, 2021, by and between Osmotica Pharmaceuticals plc and Cantor Fitzgerald & Co
Sales Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2021
Cultivation and Sales Agreement between MJ Holdings, Inc. and RK Grow LLC dated June 22, 2021
Sales Agreements
MJ Holdings, Inc.
Pharmaceuticals
NV
2021
Cultivation and Sales Agreement between MJ Holdings, Inc. and Green Grow Investments Corporation dated May 7, 2021
Sales Agreements
MJ Holdings, Inc.
Pharmaceuticals
NV
2021
Controlled Equity Offering Sales AgreementSM, dated August 12, 2021, by and between VYNE Therapeutics Inc. and Cantor Fitzgerald & Co
Sales Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021